ClinicalTrials.Veeva

Menu

Study on the Effects of a Recommendation Based Supply of Vitamin D3 in Healthy Volunteers

M

Martin-Luther-Universität Halle-Wittenberg

Status

Completed

Conditions

Deficiency of Vitamin D3

Treatments

Dietary Supplement: Vitamin D3

Study type

Interventional

Funder types

Other

Identifiers

NCT01711905
0315668

Details and patient eligibility

About

The aim of this study is to investigate whether a supplementation of 20 µg Vitamin D3 per day for 12 weeks can be used to normalize vitamin d-Status

Full description

It is the objective of this study to investigate whether a supplementation with Vitamin D3 can be used to normalize insufficient vitamin d status and reduce atherosclerotic risk factors such as hypertension, inflammation and hyperlipidemia. The research question is whether Vitamin D3 reduces the level of systemic inflammation and whether Vitamin D3 has an effect on blood lipids.

Enrollment

107 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy volunteers
  • age between 18 and 70 years
  • informed consent

Exclusion criteria

  • use of antihypertensive medication
  • use of vitamin d or calcium supplements
  • known renal, inflammatory or malignant diseases
  • hypercalcemia or hypercalciuria
  • participation in other clinical studies
  • use of tanning booths during the study
  • pregnancy or lactating period

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

107 participants in 2 patient groups

Vitamin D3
Experimental group
Description:
cholecalciferol 20 µg per day for 12 weeks
Treatment:
Dietary Supplement: Vitamin D3
Placebo
No Intervention group
Description:
Placebo for 12 weeks

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems